Alovudine F-18 Recruiting Phase 0 Trials for Acute Myeloid Leukemia (AML) / Acute Lymphoblastic Leukemia (ALL) Diagnostic

IndicationsStatusPurposePhase
RecruitingDiagnostic0
clinicaltrials.gov IdentifierTitleDrugs
NCT03422731Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy